Insiders / Mazelsky Jonathan Jay / Activity
Activity — Mazelsky Jonathan Jay
25 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $3.30M | +23K +27.90% | 106,932 0.14% of shares | low |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $2.41M | -4K -3.86% | 91,254 0.12% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.89M | -3K -3.13% | 88,395 0.11% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.88M | -3K -2.93% | 94,914 0.12% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.72M | -3K -3.00% | 83,606 0.11% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.09M | -2K -1.60% | 102,887 0.13% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $975.9K | -1K -1.48% | 99,117 0.13% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $882.1K | -1K -1.35% | 97,774 0.12% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $833.5K | -1K -1.20% | 105,651 0.13% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $793.3K | -1K -1.36% | 87,195 0.11% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $765.5K | -1K -1.14% | 101,716 0.13% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $727.3K | -1K -1.09% | 100,605 0.13% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $713.4K | -1K -1.04% | 104,556 0.13% of shares | medium |
| Feb 26, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $662.2K | -1K -1.15% | 86,195 0.11% of shares | medium |
| Feb 14, 2026 | Other | IDXX Idexx Laboratories Inc /De Common Stock | $575.9K | -915 -1.08% | 83,606 0.11% of shares | low |
| Feb 27, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $99.6K | +197 +0.24% | 83,803 0.11% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $0 | +1K +1.32% | 84,521 0.11% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $0 | +958 +1.16% | 83,422 0.11% of shares | low |
| Jan 9, 2026 | Grant | XRAY DENTSPLY SIRONA Inc. Common Stock | $0 | +395 +1.39% | 28,847 0.01% of shares | low |
| Feb 27, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Incentive Stock Option (right-to-buy) | — | -197 -100.00% | 0 0.00% of shares | low |
| Feb 26, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Non-Qualified Stock Option (right-to-buy) | — | -23K -100.00% | 0 0.00% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | -1K -50.00% | 1,099 <0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | -958 -100.00% | 0 0.00% of shares | low |
| Feb 12, 2026 | Grant | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | +13K | 13,407 0.02% of shares | low |
| Jan 9, 2026 | Grant | XRAY DENTSPLY SIRONA Inc. Phantom Stock (Directors' Deferred Compensation) DDC | — | +154 +1.07% | 14,535 <0.01% of shares | low |